241 related articles for article (PubMed ID: 30112841)
1. Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.
Boyne DJ; Mickle AT; Brenner DR; Friedenreich CM; Cheung WY; Tang KL; Wilson TA; Lorenzetti DL; James MT; Ronksley PE; Rabi DM
Cancer Med; 2018 Sep; 7(9):4801-4813. PubMed ID: 30112841
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta-analysis.
Stone CR; Mickle AT; Boyne DJ; Mohamed A; Rabi DM; Brenner DR; Friedenreich CM
Health Sci Rep; 2019 Oct; 2(10):e135. PubMed ID: 31667360
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
[TBL] [Abstract][Full Text] [Related]
5. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
6. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
9. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of cohort studies of long term outdoor nitrogen dioxide exposure and mortality.
Stieb DM; Berjawi R; Emode M; Zheng C; Salama D; Hocking R; Lyrette N; Matz C; Lavigne E; Shin HH
PLoS One; 2021; 16(2):e0246451. PubMed ID: 33539450
[TBL] [Abstract][Full Text] [Related]
11. Benzene exposure and non-Hodgkin lymphoma: a systematic review and meta-analysis of human studies.
Rana I; Dahlberg S; Steinmaus C; Zhang L
Lancet Planet Health; 2021 Sep; 5(9):e633-e643. PubMed ID: 34450064
[TBL] [Abstract][Full Text] [Related]
12. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
Salz T; Zabor EC; de Nully Brown P; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Vickers AJ; Svenssen Munksgaard P; Oeffinger KC; Johansen C
J Clin Oncol; 2017 Dec; 35(34):3837-3843. PubMed ID: 28922087
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review.
Nochaiwong S; Ruengorn C; Mongkhon P; Thavorn K; Awiphan R; Noppakun K; Vongsanim S; Chongruksut W; Hutton B; Sood MM; Knoll GA;
Medicine (Baltimore); 2020 Apr; 99(17):e19767. PubMed ID: 32332616
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
15. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.
Strongman H; Gadd S; Matthews A; Mansfield KE; Stanway S; Lyon AR; Dos-Santos-Silva I; Smeeth L; Bhaskaran K
Lancet; 2019 Sep; 394(10203):1041-1054. PubMed ID: 31443926
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
17. Radiation Therapy for Treatment of Adolescent and Young Adult Hodgkin Lymphoma and Risk for Cardiovascular Disease and Cancer.
Rugbjerg K; Olsen JH
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):1-8. PubMed ID: 30192163
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
[TBL] [Abstract][Full Text] [Related]
19. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]